Bense, S; Best, C; Buchholz, HG et al.
18F-fluorodeoxyglucose hypometabolism in cerebellar tonsil and flocculus in downbeat nystagmus.Neuroreport. Bd. 17. H. 6. 2006 S. 599-603
Schirrmacher, R; Bradtmoller, G; Schirrmacher, E et al.
18F-labeling of peptides by means of an organosilicon-based fluoride acceptorAngew Chem Int Ed Engl. Bd. 45. H. 36. 2006 S. 6047-50
Fottner, C; Rossmann, H; Schamberger, B et al.
A novel succinate dehydrogenase subunit D (SDHD) gene mutation, F136frameshift, causes familial malignant extraadrenal paragangliomas. 50th Annual Meeting of the German Society of EndocrinologyExp Clin Endocr Diab. Bd. 114. 2006 S. P05-060
Nguyen-Huu, BK; Urban, PP; Schreckenberger, M et al.
Antiamphiphysin-positive stiff-person syndrome associated with small cell lung cancer.Mov Disord. Bd. 21. H. 8. 2006 S. 1285-7
Kunkel, Martin; Helisch, Andreas; Reichert, Torsten E. et al.
Clinical and prognostic value of [18F]FDG-PET for surveillance of oral squamous cell carcinoma after surgical salvage therapyOral oncology. OO. Bd. 42. H. 3. Kidlington: Elsevier Science 2006 S. 297 - 305
Werhahn, KJ; Landvogt, C; Klimpe, S et al.
Decreased dopamine D2/D3-receptor binding in temporal lobe epilepsy: an [18F]fallypride PET studyEpilepsia. Bd. 47. H. 8. 2006 S. 1392-6
Vander Borght, T; Asenbaum, S; Bartenstein, P et al.
EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues.Eur J Nucl Med Mol Imaging. Bd. 33. H. 11. 2006 S. 1374-80
Teipel, SJ; Drzezga, A; Bartenstein, P et al.
Effects of donepezil on cortical metabolic response to activation during (18)FDG-PET in Alzheimer's disease: a double-blind cross-over trial.Psychopharmacology. Bd. 187. H. 1. 2006 S. 86-94
Buchmann, I; Hansen, T; Brochhausen, C et al.
FDG-PET in the initial staging of squamous cell oesophageal carcinoma.Nuklearmedizin. Bd. 45. H. 6. 2006 S. 235-41
Baumgartner, U; Buchholz, HG; Bellosevich, A et al.
High opiate receptor binding potential in the human lateral pain system.Neuroimage. Bd. 30. H. 3. 2006 S. 692-9